Medical Device Safety — How to Improve Histopathological Evaluations

Medical Device, Medical Device Safety and Regulation,
  • Friday, December 02, 2022

In this upcoming webinar, learn the fundamentals behind medical device evaluation — and how to better ensure the accurate histopathological evaluation of medical device safety, efficacy, heating and bio compatibility in nonclinical assessments. This webinar will benefit pathologists, trainees, scientists and study directors working in the medical device field.

This webinar will also review the histology challenges of absorbable implants, and discuss solutions to these challenges, including how to prevent histology reagents from interfering with the implant material. Attendees are invited to send in any questions they have in advance, and StageBio will be sure to address them in the webinar.

Register to learn more about determining safety endpoints and screening methods to adopt for the evaluation of medical device safety.


Serge Rousselle, StageBio

Serge Rousselle, DVM, DACVP, Distinguished Pathologist, StageBio

Dr. Serge Rousselle spent the early part of his career as a toxicologic pathologist in the pharmaceutical industry. Over time, his work has made him a luminary in medical device histopathology. As a medical device expert, Dr. Rousselle enjoys collaborative work with sponsors and colleagues and the challenges of improving the way new products are assessed and patient safety is ensured. As a Distinguished Pathologist, his work is now also focused on new imaging techniques, digital pathology and image analytics. Dr. Rousselle is an active member of ACVP and STP and has co-authored over 30 journal articles and many abstracts presented at international conventions.

Message Presenter

Who Should Attend?

  • Industry Pathologists
  • Study Directors
  • Pathology trainees and Scientists
  • Scientists working in the medical device field

What You Will Learn

Attendees will gain insights into:

  • Screening methods to adopt for the evaluation of medical devices
  • How to determine and evaluate safety endpoints
  • How to conduct nonclinical safety assessment of absorbable implants

Xtalks Partner


StageBio is a leading provider of GLP-compliant necropsy, histology, pathology, and specimen archiving services for the biopharmaceutical, medical device, academic, and contract research industries. The company operates six GLP laboratories as well as two GLP specimen archiving facilities in the U.S., with substantial continued investment in facility and technology infrastructure to meet the growing demand for high-quality histopathology services globally. StageBio has a team of 30+ board-certified veterinary pathologists and more than 100 laboratory technicians on staff supporting our unified commitment to quality, scientific integrity and client satisfaction.

You Must Login To Register for this Free Webinar

Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.

Create Account